We are live on ! Find out more
LAB icon

Standard BioTools
LAB

97 hedge funds and large institutions have $246M invested in Standard BioTools in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $229M → $246M (+$17.3M)

0% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 32

3% less call options, than puts

Call options by funds: $526K | Put options by funds: $545K

3% less funds holding

Funds holding: 100 → 97 (-3)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

Holders
97
Holders Change
-3
Holders Change %
-3%
% of All Funds
2.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
32
Reduced
32
Closed
13
Calls
$526K
Puts
$545K
Net Calls
-$19K
Net Calls Change
-$152K

Top Buyers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
+$14.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.43M
3
GTC
Ghost Tree Capital
New York
+$1.41M
4
Deutsche Bank
Deutsche Bank
Germany
+$1.12M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$10.6M
2
WA
Wasatch Advisors
Utah
-$7.03M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.9M
4
ECM
Endurant Capital Management
California
-$2.7M
5
CWAM
Columbia Wanger Asset Management
Illinois
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$1.48M – – –
GTC
27
Ghost Tree Capital
New York
$1.35M +$1.41M +150,000 New
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$1.22M +$1.12M +118,816 +740%
Goldman Sachs
29
Goldman Sachs
New York
$1.17M +$1.03M +109,847 +562%
BIM
30
BlackRock Investment Management
Delaware
$992K +$60.4K +6,429 +6%
TCIM
31
TIAA CREF Investment Management
New York
$876K -$96.8K -10,299 -10%
Charles Schwab
32
Charles Schwab
California
$816K +$12.6K +1,344 +2%
Principal Financial Group
33
Principal Financial Group
Iowa
$699K -$16.9K -1,800 -2%
Jennison Associates
34
Jennison Associates
New York
$631K -$10.6M -1,131,504 -94%
Ohio Public Employees Retirement System (OPERS)
35
Ohio Public Employees Retirement System (OPERS)
Ohio
$584K -$248K -26,402 -29%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$551K – – –
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$550K -$17.9K -1,900 -3%
PC
38
Polar Capital
United Kingdom
$489K -$97.4K -10,360 -16%
TA
39
Teachers Advisors
New York
$453K +$27.6K +2,938 +6%
IHM
40
Iguana Healthcare Management
New York
$452K -$470K -50,000 -50%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$422K -$22.3K -2,375 -5%
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$415K – – –
PP
43
PDT Partners
New York
$412K +$429K +45,600 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$378K -$33.8K -3,600 -8%
AllianceBernstein
45
AllianceBernstein
Tennessee
$376K +$30.1K +3,200 +8%
BIM
46
Bogle Investment Management
Massachusetts
$367K -$2.13M -226,227 -85%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$347K +$114K +12,175 +46%
CS
48
Credit Suisse
Switzerland
$306K -$326K -34,669 -51%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$298K +$50.1K +5,331 +19%
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$247K +$1.69K +180 +0.7%
1
2
3 4 5

LAB Hedge Fund Activity: Q2 2016 in Review

97 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2016, worth a combined $246M — up 7.6% from $229M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of LAB and 11 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 32 added.

The largest buyer was Levin Capital Strategies, adding an estimated $14.1M. The largest seller was Jennison Associates, cutting an estimated $10.6M.

  • 97 institutional investors held Standard BioTools (LAB) as of Q2 2016, down from 100 in Q1 2016.
  • Funds reported $246M of Standard BioTools stock for Q2 2016, up 7.6% quarter-over-quarter.
  • 11 funds opened new Standard BioTools positions in Q2 2016 and 13 closed out, a net change of -2 holders.
  • The largest Standard BioTools buyer in Q2 2016 was Levin Capital Strategies, an estimated $14.1M added.
  • The largest Standard BioTools seller in Q2 2016 was Jennison Associates, an estimated $10.6M sold.

Based on aggregated 13F filings for Q2 2016.